blood pressure remains controlled Medication Tolerability: Occasional early satiety reported, but no severe adverse events One-Year Visit Weight: Down 9 kg overall (BMI 31 kg/m), approaching his target of losing 1012 kg HbA1c: 6.9%, well within the personalized target range set by his endocrinologist Lifestyle: Continues brisk walking 34 times weekly and has enrolled in a weight management support group Quality of Life: Richard reports feeling more energetic, with fewer episodes of low blood sugar after the sulfonylurea dose adjustment Discussion and Alignment with Research Findings Long-Term Projection: Based on modeling data similar to the CORE diabetes model, semaglutide may offer substantial long-term benefits, including reduced risk of cardiovascular complications and improved survival (17)(18)
We simplify the process, support their journey from all angles, and help them make the most of their benefits for long-term success
Resources We Trust Mayo Clinic: Supporting Weight-Loss Medications With Adequate, Tailored Nutrition National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight & Obesity Massachusetts General Hospital: Fitness for People Taking GLP-1 Agonists: A Comprehensive Guide Cleveland Clinic: This Is How to Lose Weight the Right Way and Keep It Off Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) Vosoughi K et al
Calories burned need to be more than calories consumed
It could actually be dangerous because sometimes you have to remind yourself to eat
Long-term maintenance requires continued treatment
